Showing results (91-100 of 293) with videos related to
Sort By:
Pageof 30
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.Cancer|February 25, 2003
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patientsTakefumi Satoh, Guang Yang, Shin Egawa, et al.The Prostate|March 9, 2010
Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomesWendy J Langeberg, Salahaldin A Tahir, Ziding Feng, et al.Human Pathology|June 29, 2007
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancerRile Li, Sibel Erdamar, Hong Dai, et al.American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survivalGuang Yang, Gustavo Ayala, Angelo De Marzo, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 17, 2009
Antipsychotic effects on auditory sensory gating in schizophrenia patientsEva María Sánchez-Morla, José Luis Santos, Ana Aparicio, et al.Bipolar Disorders|June 10, 2014
A five-year follow-up study of neurocognitive functioning in bipolar disorderJosé Luis Santos, Ana Aparicio, Alexandra Bagney, et al.Journal of the National Cancer Institute|March 20, 2003
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastasesHisanori Uehara, Sun Jin Kim, Takashi Karashima, et al.Schizophrenia Research|February 16, 2010
P50 gating in deficit and nondeficit schizophreniaJosé Luis Santos, Eva María Sánchez-Morla, Ana Aparicio, et al.Pageof 30